WST•benzinga•
West Pharmaceutical Defies Doubters: EPS Jumps, Outlook Raised Despite Tariff Drag
Summary
West Pharmaceutical topped Q1 estimates and raised 2025 guidance, citing stronger device demand and improved inventory trends across key markets.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 24, 2025 by benzinga